Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 183 results
  • Sort by Sort ascending
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever

Dengue Phase2 Brazil
Colombia
India
Malaysia
Singapore
Vietnam
View All

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

Prostate Cancer Phase2, Phase3 Australia
China
Israel
Japan
Singapore
Taiwan
United States
View All

Open-label, Multi-center, Phase I/II Study to Assess Safety, Disease Progression and Cellular Kinetics Following YTB323 Administration in Participants With Non-active Progressive Multiple Sclerosis (PMS)

Progressive Multiple Sclerosis Phase1, Phase2 Australia
Canada
France
Germany
Italy
Spain
Switzerland
View All

A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult Patients With Moderate to Severe Hidradenitis Suppurativa

Hidradenitis Suppurativa Phase3 Argentina
Australia
Bulgaria
Canada
China
Denmark
Germany
Greece
Italy
Malaysia
Mexico
Poland
Portugal
Slovakia
South Africa
Spain
Taiwan
United States
View All

Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis

Generalized Myasthenia Gravis Phase1, Phase2 France
Japan
United Kingdom
United States
View All

Kesimpta (Ofatumumab) in Greek Multiple Sclerosis Patients - an Observational Study

Relapsing Multiple Sclerosis (RMS) Greece

Entresto Tablets and Granules for Pediatric Specified Drug-use Survey (Pediatric Chronic Heart Failure)

Pediatric Chronic Heart Failure Japan

Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

Familial Hypercholesterolemia - Heterozygous Phase3 Argentina
Austria
Belgium
Brazil
China
Czechia
France
Germany
Greece
Hong Kong
Hungary
Israel
Italy
Malaysia
Netherlands
Poland
Portugal
South Africa
Spain
Taiwan
Turkey (Türkiye)
United Kingdom
United States
View All

A Prospective Non-interventional Study to Evaluate Clinical Outcomes of Ribociclib Combined With Endocrine Therapy in Elderly Patients With HR+HER2 - Advanced Breast Cancer in Routine Clinical Practice in Russian Federation

HR+HER2- Advanced Breast Cancer Russia

An Open-label Study to Assess the Safety, Efficacy, and Cellular Kinetics of YTB323 in Relapsing Multiple Sclerosis

Relapsing Multiple Sclerosis Phase1, Phase2 Australia
France
Germany
Italy
Spain
Switzerland
View All